<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000306513"><TermName>rasburicase</TermName><TermPronunciation>(ras-BUR-ih-kays)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat high blood levels of uric acid in patients with leukemia, lymphoma, and other types of cancer who are receiving certain types of cancer treatment. It is also being studied in the treatment of other medical conditions.  Rasburicase is a type of recombinant enzyme and a type of urate-lowering drug. Also called Elitek and recombinant urate oxidase.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711504" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rasburicase&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711503" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rasburicase&quot;" language="es" id="_4"/><SpanishTermName>rasburicase</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar concentraciones altas de ácido úrico en pacientes con leucemia, linfoma y otros tipos de cáncer que se encuentran bajo ciertos tratamientos. También está en estudio para el tratamiento de otras afecciones médicas.  El rasburicase es un tipo de  enzima recombinante y un tipo de medicamento que disminuye el urato. También se llama Elitex y urato oxidasa recombinante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-05-23</DateFirstPublished><DateLastModified>2009-11-10</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000658556">Rasburicase</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
